The treatment of systemic lupus erythematosus (SLE) nephritis, while effective, is associated with significant morbidity and mortality. These side effects could be mitigated if the onset, severity, and response of renal flare could be predicted, and therapy modified accordingly. In this review, an approach to derive prediction equations of SLE nephritis flare is discussed. Integral to generating such prediction equations is the identification of biomarkers of lupus nephritis that can serve as input variables for modeling flare. The use of urine as a source of SLE nephritis biomarkers is described, and the results of urine biomarker discovery studies using candidate and proteomic approaches are presented.
Biomarker discovery in human SLE nephritis. Publishing Authors By Initials
Biomarker discovery in human SLE nephritis. Journal Published:
PUBLICATION TYPE: Research Support, N.I.H., Extr
Journal: Bulletin of the NYU hospital for joint diseases
VOLUME: 65
Page Numbers: 187-93
Journal Abbreviation:
ISSN: 1936-9719
DAY: 9
MONTH: 10
YEAR: 2007
Biomarker discovery in human SLE nephritis. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 101300541
Biomarker discovery in human SLE nephritis. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Biomarker discovery in human SLE nephritis. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Biomarker discovery in human SLE nephritis.
AFFILIATION: Division of Nephrology, Ohio State University College of Medicine, and Columbus Children's Hospital Research Center 43210, USA. Rovin.1@osu.edu
Country: United States
AGENCY: United States NIDDK
GRANT: P01 DK55546
ACRONYM: DK
MEDLINETA: Bull NYU Hosp Jt Dis
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Biomarker discovery in human SLE nephritis Related Publications